<p>In the TNF1 group, 146 patients (72.3%) had no MH, while 56 patients (27.7%) had MH. In the TNF2 group, 13 patients (28.6%) patients had MH, while 33 patients (71.4%) had no MH at follow-up colonoscopy.</p
Background: Infliximab (IFX) treatment induces mucosal healing (MH) in patients with Crohn's disease...
Mucosal healing is one of the main aims of therapy in Crohn’s disease. Although, mucosal...
BACKGROUND & AIMS: Few prospective data are available to support the clinical relevance of mucosal h...
<div><p>Objective</p><p>Mucosal healing (MH) is an important treatment goal in patients with inflamm...
Mucosal healing (MH) is an important treatment goal in patients with inflammatory bowel disease (IBD...
<p>The cumulative proportions of mucosal healing in the non-abdominal pain group in the 1<sup>st</su...
<p>At follow-up colonoscopy, CRP values were significantly lower in patients with MH compared to pat...
Background: Transmural healing (TH) of Crohn’s disease (CD) is a still unexplored and interesting ou...
<p>At follow-up colonoscopy, there was a trend for lower CRP in patients with MH compared to patient...
Background: While mucosal healing has been proved to predict relevant clinical outcomes in Crohn's d...
Nowadays, mucosal healing is regarded as a major end point in clinical trials and is increasingly us...
Mucosal healing [MH] is an important goal for patients with Crohn's disease [CD], yet is incompletel...
<p>During the follow-up time, no patient with MH underwent surgery as compared to 10 patients withou...
<p>During the follow-up time, 3 patients with MH underwent surgery as compared to 31 patients withou...
BACKGROUND: Mucosal healing (MH) has emerged as a therapeutic goal in the treatment of inflammatory ...
Background: Infliximab (IFX) treatment induces mucosal healing (MH) in patients with Crohn's disease...
Mucosal healing is one of the main aims of therapy in Crohn’s disease. Although, mucosal...
BACKGROUND & AIMS: Few prospective data are available to support the clinical relevance of mucosal h...
<div><p>Objective</p><p>Mucosal healing (MH) is an important treatment goal in patients with inflamm...
Mucosal healing (MH) is an important treatment goal in patients with inflammatory bowel disease (IBD...
<p>The cumulative proportions of mucosal healing in the non-abdominal pain group in the 1<sup>st</su...
<p>At follow-up colonoscopy, CRP values were significantly lower in patients with MH compared to pat...
Background: Transmural healing (TH) of Crohn’s disease (CD) is a still unexplored and interesting ou...
<p>At follow-up colonoscopy, there was a trend for lower CRP in patients with MH compared to patient...
Background: While mucosal healing has been proved to predict relevant clinical outcomes in Crohn's d...
Nowadays, mucosal healing is regarded as a major end point in clinical trials and is increasingly us...
Mucosal healing [MH] is an important goal for patients with Crohn's disease [CD], yet is incompletel...
<p>During the follow-up time, no patient with MH underwent surgery as compared to 10 patients withou...
<p>During the follow-up time, 3 patients with MH underwent surgery as compared to 31 patients withou...
BACKGROUND: Mucosal healing (MH) has emerged as a therapeutic goal in the treatment of inflammatory ...
Background: Infliximab (IFX) treatment induces mucosal healing (MH) in patients with Crohn's disease...
Mucosal healing is one of the main aims of therapy in Crohn’s disease. Although, mucosal...
BACKGROUND & AIMS: Few prospective data are available to support the clinical relevance of mucosal h...
DOI
Add to ORKG